Healthcare >> CEO Interviews >> July 1, 1998
DAVID W. BARRY, M.D. founded Triangle Pharmaceuticals, Inc. in 1995 and
is Chairman and CEO. Dr. Barry received his undergraduate education at
the Sorbonne and Yale University where he graduated magna cum laude in
1965. While earning his M.D. degree at Yale, he began his career in
Virology in 1967 as a Research Associate at the Rockefeller Foundation-
Yale Arborvirus Research Unit. Following internship and residency
training at Yale New Haven Hospital, Dr. Barry joined the Food and Drug
Administration in 1972, where he was director of the General Virology
Branch and later acting deputy director of the Division of Virology as
well as director of the Influenza Task Force. Dr. Barry joined Burroughs
Wellcome in 1977 as head of the Department of Virology and director of
clinical investigation. Dr. Barry was named vice president of research,
development & medical affairs (RD&M) at Burroughs Wellcome in September
of 1989 and group director of RD&M in 1994. He was also a member of the
Board of Directors of the Burroughs Wellcome Co., the Wellcome
Foundation and Family Health International. He is currently Chairman of
the Inter-Company Collaboration of AIDS Drug Development. Dr. Barry is a
Board Certified Specialist in Internal Medicine and Infectious Diseases,
and an Adjunct Professor of Medicine at Duke University. He has written
nearly 100 scientific articles and is a co-inventor of the use of AZT to
treat HIV infections. Profile
sketch on Triangle Pharmaceuticals? And then, bring us up-to-date, what
do you see over the next two to three years as the
